查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1830998

機器人輔助手術系統市場

Robotic Assisted Surgery Systems Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5個工作天內

價格
簡介目錄

機器人輔助手術系統市場預計將從 2022 年的 93.1 億美元擴大到 2031 年的 253.8 億美元，2025 年至 2031 年期間的複合年成長率預計為 14.9%。

市場洞察與分析師觀點：機器人輔助手術系統市場涵蓋各種先進的手術平台，這些平台結合了機器人技術、影像技術和導航技術，幫助外科醫生以更高的精度和控制力進行微創手術。這些系統旨在提高手術能力，改善患者預後，並減少傳統手術方法的創傷。機器人輔助手術系統的主要優勢包括更高的靈活性、3D可視化和震顫抑制，使外科醫生能夠更精確、更靈活地執行複雜的手術。這些系統通常有助於進入具有挑戰性的解剖區域，從而減少患者的創傷並加快康復時間。此外，在手術過程中加入機器人技術可以降低併發症的可能性，減少輸血需求，最終獲得更好的術後效果。

成長動力與挑戰：越來越多的研究計畫旨在探討機器人輔助手術的優勢和功能，預計在未來幾年推動市場成長。 2022年9月，名古屋市立大學（NCU）醫學研究生院的研究人員進行了一項研究，比較了機器人輔助、螢光透視引導和超音波引導下經皮腎鏡取石術（PCNL）的腎臟通路。研究結果表明，創新機器人設備安全可靠且方便用戶使用，可以減輕外科醫生的培訓需求，並使更多醫院能夠進行經皮腎鏡取石術（PCNL）。這種利用人工智慧驅動的機器人技術的方法，或將為類似外科手術的自動化鋪平道路，從而加快手術進程並降低併發症風險。

慢性病盛行率的上升以及人們對微創手術的日益青睞，進一步支撐了機器人輔助手術系統市場的成長。根據《印度教徒報》2022年8月報道，印度海德拉巴的阿波羅健康城已成功完成500多例機器人輔助婦科手術。 2022年11月，美敦力公司（Medtronic plc）的子公司印度美敦力私人有限公司（India Medtronic Private Limited）與德里的文卡特什瓦爾醫院（Venkateshwar Hospital）宣布，在印度北部完成了首例使用Hugo機器人輔助手術（RAS）系統的泌尿外科手術。

相反，機器人手術系統的高昂成本對醫療機構的財務可行性和營運永續性構成了挑戰。雖然這些系統具有提高精準度、降低創傷性和縮短恢復時間等優勢，但巨額的初始投資和持續的維護費用需要醫療機構進行周密的財務規劃和資源分配。此外，手術人員需要接受專門的培訓和認證才能操作這些系統，這也增加了營運成本，影響了將機器人手術納入現有臨床實踐的整體可負擔性和實用性。與機器人手術系統相關的財務負擔可能會影響醫療保健報銷模式和覆蓋範圍決策，因為使用機器人輔助進行的手術的報銷率可能有所不同，從而影響採用這些技術的經濟合理性。這造成了一個複雜的局面，醫療機構必須在機器人手術的臨床效益和財務影響之間取得平衡，這可能會影響不同醫療保健系統的採用速度和範圍。

策略洞察報告細分和範圍：機器人輔助手術系統市場根據產品類型、應用和最終用戶進行分類。就產品類型而言，市場分為系統、儀器和配件以及服務。根據應用，市場細分為婦科手術、心血管手術、神經外科、骨科手術、腹腔鏡手術、泌尿科、一般外科等。根據最終用戶，市場分為醫院、門診手術中心和其他最終用戶。從地理上講，機器人輔助手術系統市場分為北美（美國、加拿大和墨西哥）、歐洲（英國、德國、法國、義大利、西班牙和歐洲其他地區）、亞太地區（中國、日本、印度、韓國、澳洲和亞太其他地區）、中東和非洲（阿拉伯聯合大公國、沙烏地阿拉伯、南非和中東和非洲其他地區）以及南美洲和中美洲（巴西、阿根廷和南美洲和其他地區）。

分部分析：就產品類型而言，手術機器人部分在 2022 年佔據了機器人輔助手術系統市場相當大的收入佔有率。由於全球心血管和癌症相關疾病的發生率不斷上升，預計對進行精確和準確手術的手術機器人的需求將會上升。美國癌症協會的《2023 年癌症統計數據》預測，美國將在 2023 年報告 190 萬例新的癌症病例。根據澳洲健康與福利研究所 (AIHW) 2021 年的報告，2021 年澳洲估計有 150,800 例新的癌症病例。澳洲統計局在 2022 年 3 月報告稱，估計約有 4.0% 的澳洲人（100 萬人）在 2021 年患有心臟病。

根據應用，機器人輔助手術系統市場可分為婦科手術、心血管手術、神經外科、骨科手術、腹腔鏡手術、泌尿科、一般外科及其他。預計神經外科領域在2022年至2030年期間的複合年成長率最高。手術機器人在一般外科手術中的日益普及及其相對於傳統手術方法的優勢，將對整個市場產生正面影響。此外，技術進步和機器人神經外科手術的成功經驗預計將在未來幾年推動機器人輔助手術系統市場的成長。根據SS Innovations Interventional Inc.的數據，2020年全球約有160萬例機器人手術。

按最終用戶分類，機器人輔助手術系統市場可細分為醫院、門診手術中心和其他最終用戶。醫院領域在2022年佔據市場主導地位，預計2022年至2030年期間將達到高複合年成長率。醫院領域的成長歸因於各經濟體醫療成本的上漲。醫院利用最新的機器人輔助手術技術提供高品質的醫療服務。此外，醫生和外科醫生也青睞機器人輔助系統。根據《美國醫學會雜誌》(JAMA) 網路發表的一篇論文報導，機器人輔助手術在外科手術總量中所佔的比例已從2013年的1.8%顯著上升至2019年的15.1%。

區域分析：從地理來看，機器人輔助手術系統市場分為北美、歐洲、亞太地區、中東和非洲以及南美和中美。北美是該市場成長的最大貢獻者。該地區市場的成長得益於美國自動化手術器械的使用日益增多以及下一代醫療保健系統的採用。此外，美國外科醫生和醫療專業人員相對於患者群體的短缺預計將使機器人輔助手術系統市場受益。糖尿病、癌症和心血管疾病等慢性疾病的盛行率不斷上升，正在推動美國對機器人輔助手術系統的需求。

與傳統手術相比，人們對微創手術的日益青睞推動了機器人輔助手術系統市場的發展。據美敦力公司稱，2022年12月，Hugo在美國擴大了其機器人輔助手術 (RAS) 系統的臨床試驗，並招募了首位患者。此外，2022年，北卡羅來納州達勒姆市杜克大學醫院的一位醫生實施了機器人輔助前列腺切除術。

預計 2022 年至 2030 年間，亞太地區機器人輔助手術系統市場將以最快的複合年成長率成長，這得益於患者人數的增加和先進自動化手術器械的普及。此外，現代醫療設施的擴張和公眾對先進醫療技術益處的認知不斷提高，預計將在未來支持該地區的市場成長。亞太各國政府正努力發展先進的醫療基礎設施，吸引國際企業在該地區投資建立自動化器材開發設施。中國在亞太地區機器人輔助手術系統市場中佔有最大佔有率，而印度預計將在 2022 年至 2030 年間實現最高的複合年成長率。中國手術機器人領域的公司利用特殊的核准途徑加快了創新醫療產品的法規核准，縮短了產品上市時間。此外，中國正在湧現越來越多專門從事手術機器人的醫療科技公司。近期，健嘉機器人和Hurwa公司進軍中國市場，攜手專注於骨科手術機器人的本土公司天威科技（TINAVI）共同開發手術機器人解決方案。北京為天威機器人輔助的脊椎、髖關節和膝關節手術提供報銷。

機器人輔助手術系統市場報告範圍產業發展與未來機會：全球機器人輔助手術系統市場主要參與者採取的關鍵措施包括：

2023年10月，DePuy Synthes旗下的強生醫療科技公司（Johnson & Johnson MedTech）推出了VELYS機器人輔助解決方案，該解決方案已在德國、比利時和瑞士的全膝關節置換手術中得到應用。此次發布擴展了DePuy Synthes在其數位手術平台中的聯網技術，以符合骨科機器人領域尚未滿足的需求。

2022年11月，一家印度醫療科技公司與美國納斯達克上市公司Avra Medical Robotics達成合作。 SS Innovations推出了SSI Mantra，這是第一款完全「印度製造」的手術機器人，它是一款高度先進的手術機器人系統，其功能和應用範圍比其他系統更廣泛。

2022 年 11 月，美國 FDA 批准了 Accelus 的 Remi 機器人導航系統軟體更新，使進行腰椎固定的外科醫生能夠在機器人協助下放置椎弓根螺釘。 Accelus 是一家私人醫療技術公司，致力於推廣微創手術 (MIS) 作為脊椎手術的護理標準。競爭格局與主要公司：機器人輔助手術系統市場的知名企業包括 Intuitive Surgical Inc.、Stryker Corporation、Johnson & Johnson Inc.、SRI International Inc.、Accuray Incorporated、Renishaw PLC、Medtronic PLC、Brainlab、Smith & Nephew PLC、Globus 和 Zimmer Biomet。這些公司專注於擴大其產品範圍，以滿足日益成長的全球需求。他們的國際影響力使他們能夠服務廣泛的客戶群，從而提高他們的市場佔有率。

目錄

第1章：簡介

第2章：執行摘要

  • 關鍵見解
  • 市場吸引力分析

第3章：研究方法

第4章：機器人輔助手術系統市場格局

  • 概述
  • PEST分析
  • 生態系分析
    • 價值鏈中的供應商列表

第5章：機器人輔助手術系統市場－關鍵市場動態

  • 關鍵市場促進因素
  • 主要市場限制因素
  • 關鍵市場機會
  • 未來趨勢
  • 促進因素和限制因素的影響分析

第6章：機器人輔助手術系統市場-全球市場分析

  • 機器人輔助手術系統－全球市場概覽
  • 機器人輔助手術系統－全球市場及2030年預測

第7章：機器人輔助手術系統市場-收入分析-依產品類型，2020-2030

  • 概述
  • 系統
  • 耗材及配件
  • 軟體和服務

第 8 章：機器人輔助手術系統市場 - 收入分析 - 按應用，2020-2030 年

  • 概述
  • 婦科手術
  • 心血管
  • 神經外科
  • 骨科手術
  • 腹腔鏡檢查
  • 泌尿科
  • 其他應用

第9章：機器人輔助手術系統市場-收入分析-按最終用戶，2020-2030

  • 概述
  • 醫院
  • 門診手術中心
  • 其他最終用戶

第 10 章：機器人輔助手術系統市場 - 收入分析，2020-2030 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 英國
    • 歐洲其他地區
  • 亞太
    • 澳洲
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第 11 章：新冠疫情前後的影響

第 12 章：產業格局

  • 併購
  • 協議、合作、合資企業
  • 新產品發布
  • 擴張和其他策略發展

第 13 章：競爭格局

  • 關鍵參與者的熱圖分析
  • 公司定位與集中度

第 14 章：機器人輔助手術系統市場 - 主要公司簡介

  • Intuitive Surgical Inc.
  • Stryker Corporation
  • Johnson and Johnson Inc.
  • SRI International Inc.
  • Accuray Incorporated
  • Renishaw PLC
  • Medtronic PLC
  • Smith and Nephew PLC
  • Brainlab
  • Globus Medical

第 15 章：附錄

簡介目錄
Product Code: TIPRE00004753

The market for robotic-assisted surgery systems is expected to expand from US$ 9.31 billion in 2022 to US$ 25.38 billion by 2031, with a projected CAGR of 14.9% during the period from 2025 to 2031.

Market Insights and Analyst View:The robotic-assisted surgery systems market includes a variety of advanced surgical platforms that combine robotics, imaging, and navigation technologies to aid surgeons in conducting minimally invasive procedures with enhanced precision and control. These systems aim to improve surgical capabilities, enhance patient outcomes, and reduce the invasiveness associated with traditional surgical methods. Key advantages of robotic-assisted surgery systems include improved dexterity, three-dimensional visualization, and tremor suppression, enabling surgeons to execute complex procedures with greater accuracy and flexibility. These systems often facilitate access to challenging anatomical regions, resulting in less trauma and quicker recovery times for patients. Furthermore, the incorporation of robotics in surgical procedures reduces the likelihood of complications and decreases the need for blood transfusions, ultimately leading to better post-operative results.

Growth Drivers and Challenges:The rising number of research initiatives investigating the advantages and functionalities of robot-assisted surgeries is expected to drive market growth in the upcoming years. In September 2022, researchers from the Graduate School of Medical Sciences at Nagoya City University (NCU) conducted a study comparing robotic-assisted, fluoroscopic-guided, and ultrasound-guided renal access for percutaneous nephrolithotomy. The results indicated the safety and user-friendliness of innovative robotic devices, which could alleviate the training demands on surgeons and enable more hospitals to perform PCNL procedures. This approach, utilizing AI-driven robotics, may pave the way for the automation of similar surgical interventions, thereby expediting processes and reducing complication risks.

The increase in chronic disease prevalence and the rising preference for minimally invasive surgeries further support the growth of the robotic-assisted surgical systems market. According to a report by The Hindu in August 2022, Apollo Health City in Hyderabad, India, has successfully completed over 500 robot-assisted gynecological surgeries. In November 2022, India Medtronic Private Limited, a subsidiary of Medtronic plc, and Venkateshwar Hospital in Delhi announced the completion of the first urological procedure in northern India using the Hugo robotic-assisted surgery (RAS) system.

Conversely, the high costs associated with robotic surgical systems pose challenges to the financial feasibility and operational sustainability of healthcare providers. While these systems provide benefits such as enhanced precision, reduced invasiveness, and shorter recovery times, the significant initial investment and ongoing maintenance expenses require careful financial planning and resource allocation for healthcare facilities. Additionally, the necessity for specialized training and certification for surgical staff to operate these systems adds to operational costs, affecting the overall affordability and practicality of incorporating robotic surgery into existing clinical practices. The financial burden linked to robotic surgical systems may influence healthcare reimbursement models and coverage decisions, as reimbursement rates for procedures performed with robotic assistance can vary, impacting the economic justification for adopting these technologies. This creates a complex scenario where healthcare facilities must balance the clinical benefits of robotic surgery against the financial implications, potentially affecting the rate and extent of adoption across various healthcare systems.

Strategic Insights

Report Segmentation and Scope:The robotic-assisted surgery systems market is categorized based on product type, application, and end user. In terms of product type, the market is divided into systems, instruments and accessories, and services. By application, the market is segmented into gynecological surgery, cardiovascular, neurosurgery, orthopedic surgery, laparoscopy, urology, general surgery, and others. Based on end user, the market is classified into hospitals, ambulatory surgery centers, and other end users. Geographically, the robotic-assisted surgery systems market is divided into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and the rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, South Africa, and the rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the rest of South & Central America).

Segmental Analysis:In terms of product type, the surgical robot segment accounted for a significant revenue share of the robotic-assisted surgery systems market in 2022. The demand for surgical robots to conduct precise and accurate procedures is expected to rise due to the increasing global incidence of cardiovascular and cancer-related disorders. The American Cancer Society's Cancer Statistics 2023 predicts that the US will report 1.9 million new cancer cases in 2023. According to the Australian Institute of Health and Welfare's (AIHW) 2021 report, there were an estimated 150,800 new cancer cases in Australia in 2021. The Australian Bureau of Statistics reported in March 2022 that approximately 4.0% of Australians, or 1.0 million people, were estimated to have heart disease in 2021.

By application, the robot-assisted surgical systems market is categorized into gynecological surgery, cardiovascular, neurosurgery, orthopedic surgery, laparoscopy, urology, general surgery, and others. The neurology sector is anticipated to experience the fastest CAGR from 2022 to 2030. The increasing adoption of surgical robots in general surgeries and the advantages they provide over traditional surgical methods are beneficial to the overall market. Additionally, advancements in technology and successful outcomes in robotic neurosurgery are expected to drive the growth of the robotic-assisted surgical systems market in the coming years. According to SS Innovations Interventional Inc., around 1.6 million robotic surgeries were performed globally in 2020.

By end user, the robot-assisted surgical systems market is segmented into hospitals, ambulatory surgical centers, and other end users. The hospital segment led the market in 2022 and is projected to register a high CAGR from 2022 to 2030. The growth of the hospital segment is attributed to rising healthcare costs across various economies. Hospitals provide high-quality care by utilizing the latest robotic-assisted surgical technologies. Moreover, physicians and surgeons favor robot-assisted systems. The proportion of robot-assisted surgeries in total surgical procedures increased significantly from 1.8% in 2013 to 15.1% in 2019, as reported in a paper published in the JAMA network.

Regional Analysis:Geographically, the robotic-assisted surgery systems market is divided into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is the largest contributor to the growth of this market. The market growth in this region is driven by the increasing use of automated surgical instruments and the adoption of next-generation healthcare systems in the US. Additionally, the shortage of surgeons and medical professionals in the US relative to the patient population is expected to benefit the market for robotic-assisted surgical systems. The rising prevalence of chronic diseases such as diabetes, cancer, and cardiovascular conditions is driving demand for robotic-assisted surgical systems in the US.

The growing preference for minimally invasive procedures over traditional surgeries supports the robotic-assisted surgery systems market. In December 2022, Hugo expanded its clinical trials for its robotic-assisted surgery (RAS) systems in the US by enrolling their first patient, according to Medtronic plc. Furthermore, in 2022, a physician at Duke University Hospital in Durham, North Carolina, performed a robotic-assisted prostatectomy.

The Asia Pacific robotic-assisted surgical systems market is projected to grow at the fastest CAGR from 2022 to 2030, driven by the increasing patient population and the rising adoption of advanced automated surgical instruments. Additionally, the expansion of modern healthcare facilities and growing public awareness of the benefits of advanced medical technologies are expected to support market growth in this region in the future. Governments in Asia Pacific countries are making efforts to develop sophisticated healthcare infrastructure, attracting international companies to invest in the establishment of automated instrument development facilities in the region. China holds the largest share of the robotic-assisted surgical systems market in Asia Pacific, while India is expected to achieve the highest CAGR from 2022 to 2030. Companies in the surgical robotics sector in China have expedited their time to market by utilizing a special approval pathway that accelerates regulatory approval for innovative medical products. Moreover, a growing number of medtech firms specializing in surgical robotics are emerging in the country. Recently, JianJia Robots and Hurwa entered the Chinese market to develop surgical robotics solutions alongside TINAVI, a domestic company focused on orthopedic surgical robots. Beijing provides reimbursement for TINAVI robot-assisted surgeries for spinal, hip, and knee procedures.

Robotic Assisted Surgery Systems Market Report Scope

Industry Developments and Future Opportunities:Key initiatives undertaken by major players in the global robotic-assisted surgery systems market include:

In October 2023, Johnson & Johnson MedTech, a division of DePuy Synthes, launched the VELYS Robotic Assisted Solution, which has been utilized in total knee replacement surgeries in Germany, Belgium, and Switzerland. This launch expands DePuy Synthes' networked technologies within its Digital Surgery Platform to address unmet needs for orthopedic robots.

In November 2022, an Indian Medtech company partnered with Avra Medical Robotics, an American Nasdaq-listed firm. SS Innovations introduced the SSI Mantra, the first surgical robot entirely "Made in India," which is a highly advanced surgical robotic system with more features and applications than other systems available.

In November 2022, the FDA in the United States approved an update to Accelus's software for the Remi Robotic Navigation System, enabling surgeons performing lumbar spine fixation to place pedicle screws with robotic assistance. Accelus is a private medical technology company focused on promoting minimally invasive surgery (MIS) as the standard of care in spine procedures.

Competitive Landscape and Key Companies:Prominent players in the robotic-assisted surgery systems market include Intuitive Surgical Inc., Stryker Corporation, Johnson & Johnson Inc., SRI International Inc., Accuray Incorporated, Renishaw PLC, Medtronic PLC, Brainlab, Smith & Nephew PLC, Globus Medical, and Zimmer Biomet. These companies are focused on expanding their product offerings to meet the increasing global demand. Their international presence enables them to serve a broad customer base, thereby allowing them to enhance their market share.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Definition, Assumptions and Limitations
  • 1.3 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness Analysis

3. Research Methodology

4. Robotic Assisted Surgery Systems Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 List of Vendors in the Value Chain

5. Robotic Assisted Surgery Systems Market - Key Market Dynamics

  • 5.1 Key Market Drivers
  • 5.2 Key Market Restraints
  • 5.3 Key Market Opportunities
  • 5.4 Future Trends
  • 5.5 Impact Analysis of Drivers and Restraints

6. Robotic Assisted Surgery Systems Market - Global Market Analysis

  • 6.1 Robotic Assisted Surgery Systems - Global Market Overview
  • 6.2 Robotic Assisted Surgery Systems - Global Market and Forecast to 2030

7. Robotic Assisted Surgery Systems Market - Revenue Analysis (USD Million) - By Product Type, 2020-2030

  • 7.1 Overview
  • 7.2 System
  • 7.3 Consumable and Accessories
  • 7.4 Software and Services

8. Robotic Assisted Surgery Systems Market - Revenue Analysis (USD Million) - By Application, 2020-2030

  • 8.1 Overview
  • 8.2 Gynecological Surgery
  • 8.3 Cardiovascular
  • 8.4 Neurosurgery
  • 8.5 Orthopedic Surgery
  • 8.6 Laparoscopy
  • 8.7 Urology
  • 8.8 Other Applications

9. Robotic Assisted Surgery Systems Market - Revenue Analysis (USD Million) - By End User, 2020-2030

  • 9.1 Overview
  • 9.2 Hospitals
  • 9.3 Ambulatory Surgery Centers
  • 9.4 Other End Users

10. Robotic Assisted Surgery Systems Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis

  • 10.1 North America
    • 10.1.1 North America Robotic Assisted Surgery Systems Market Overview
    • 10.1.2 North America Robotic Assisted Surgery Systems Market Revenue and Forecasts to 2030
    • 10.1.3 North America Robotic Assisted Surgery Systems Market Revenue and Forecasts and Analysis - By Product Type
    • 10.1.4 North America Robotic Assisted Surgery Systems Market Revenue and Forecasts and Analysis - By Application
    • 10.1.5 North America Robotic Assisted Surgery Systems Market Revenue and Forecasts and Analysis - By End User
    • 10.1.6 North America Robotic Assisted Surgery Systems Market Revenue and Forecasts and Analysis - By Countries
      • 10.1.6.1 United States Robotic Assisted Surgery Systems Market
        • 10.1.6.1.1 United States Robotic Assisted Surgery Systems Market, by Product Type
        • 10.1.6.1.2 United States Robotic Assisted Surgery Systems Market, by Application
        • 10.1.6.1.3 United States Robotic Assisted Surgery Systems Market, by End User
      • 10.1.6.2 Canada Robotic Assisted Surgery Systems Market
        • 10.1.6.2.1 Canada Robotic Assisted Surgery Systems Market, by Product Type
        • 10.1.6.2.2 Canada Robotic Assisted Surgery Systems Market, by Application
        • 10.1.6.2.3 Canada Robotic Assisted Surgery Systems Market, by End User
      • 10.1.6.3 Mexico Robotic Assisted Surgery Systems Market
        • 10.1.6.3.1 Mexico Robotic Assisted Surgery Systems Market, by Product Type
        • 10.1.6.3.2 Mexico Robotic Assisted Surgery Systems Market, by Application
        • 10.1.6.3.3 Mexico Robotic Assisted Surgery Systems Market, by End User
  • 10.2 Europe
    • 10.2.1 Germany
    • 10.2.2 France
    • 10.2.3 Italy
    • 10.2.4 Spain
    • 10.2.5 United Kingdom
    • 10.2.6 Rest of Europe
  • 10.3 Asia-Pacific
    • 10.3.1 Australia
    • 10.3.2 China
    • 10.3.3 India
    • 10.3.4 Japan
    • 10.3.5 South Korea
    • 10.3.6 Rest of Asia-Pacific
  • 10.4 Middle East and Africa
    • 10.4.1 South Africa
    • 10.4.2 Saudi Arabia
    • 10.4.3 U.A.E
    • 10.4.4 Rest of Middle East and Africa
  • 10.5 South and Central America
    • 10.5.1 Brazil
    • 10.5.2 Argentina
    • 10.5.3 Rest of South and Central America

11. Pre and Post Covid-19 Impact

12. Industry Landscape

  • 12.1 Mergers and Acquisitions
  • 12.2 Agreements, Collaborations, Joint Ventures
  • 12.3 New Product Launches
  • 12.4 Expansions and Other Strategic Developments

13. Competitive Landscape

  • 13.1 Heat Map Analysis by Key Players
  • 13.2 Company Positioning and Concentration

14. Robotic Assisted Surgery Systems Market - Key Company Profiles

  • 14.1 Intuitive Surgical Inc.
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Stryker Corporation
  • 14.3 Johnson and Johnson Inc.
  • 14.4 SRI International Inc.
  • 14.5 Accuray Incorporated
  • 14.6 Renishaw PLC
  • 14.7 Medtronic PLC
  • 14.8 Smith and Nephew PLC
  • 14.9 Brainlab
  • 14.10 Globus Medical

15. Appendix

  • 15.1 Glossary
  • 15.2 About The Insight Partners
  • 15.3 Market Intelligence Cloud